Project Details
Description
A prospective, multi-centre, epidemiological observational study designed to evaluate the prevalence of BRCA1 and BRCA2 (BReast CAncer gene) mutations in current and newly diagnosed ovarian cancer patients across different countries in the Gulf region. This study will also describe the epidemiological features for the disease for the enrolled patients.
| Acronym | PREDICT |
|---|---|
| Status | Finished |
| Effective start/end date | 16/07/17 → 24/07/19 |
Collaborative partners
- AstraZeneca (lead)
- Abu Dhabi Health Services Company
Keywords
- Endocrine Gland Neoplasms
- Neoplasms by Site
- Neoplasms
- Ovarian Diseases
- Adnexal Diseases
- Genital Diseases, Female
- Female Urogenital Diseases
- Pregnancy Complications
- Urogenital Diseases
- Genital Neoplasms, Female
- Urogenital Neoplasms
- Genital Diseases
- Endocrine System Diseases
- Gonadal Disorders
- Carcinoma
- Neoplasms, Glandular
- Epithelial
- Neoplasms by Histologic Type
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.